Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: QIAGEN, LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-07-29 to 2024-07-31
Current total value of award: $351525
Description: BASE PERIOD OPTIONAL QUANTITY - 56 GENE CUSTOM NEURO SOLID TUMOR AND 161 GENE THERMO FISHER ONCOMINE V3 OPTION PERIOD ONE